ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/10/11 | 1,908 | 1,915 | 1,892 | 1,895 | -5 | -0.3% | 72,100 |
2019/10/10 | 1,895 | 1,905 | 1,868 | 1,900 | +5 | +0.3% | 67,200 |
2019/10/09 | 1,892 | 1,906 | 1,882 | 1,895 | -11 | -0.6% | 71,500 |
2019/10/08 | 1,896 | 1,911 | 1,885 | 1,906 | +21 | +1.1% | 76,200 |
2019/10/07 | 1,863 | 1,885 | 1,859 | 1,885 | +14 | +0.7% | 50,200 |
2019/10/04 | 1,860 | 1,873 | 1,840 | 1,871 | +10 | +0.5% | 71,200 |
2019/10/03 | 1,873 | 1,873 | 1,849 | 1,861 | -43 | -2.3% | 57,100 |
2019/10/02 | 1,905 | 1,926 | 1,894 | 1,904 | -8 | -0.4% | 65,000 |
2019/10/01 | 1,891 | 1,923 | 1,891 | 1,912 | +14 | +0.7% | 61,000 |
2019/09/30 | 1,883 | 1,899 | 1,876 | 1,898 | -8 | -0.4% | 94,500 |
2019/09/27 | 1,947 | 1,952 | 1,884 | 1,906 | -57 | -2.9% | 112,900 |
2019/09/26 | 1,966 | 1,995 | 1,956 | 1,963 | +2 | +0.1% | 210,300 |
2019/09/25 | 1,952 | 1,965 | 1,937 | 1,961 | +4 | +0.2% | 93,200 |
2019/09/24 | 1,958 | 1,991 | 1,954 | 1,957 | +6 | +0.3% | 131,400 |
2019/09/20 | 1,940 | 1,955 | 1,921 | 1,951 | +15 | +0.8% | 119,200 |
2019/09/19 | 1,920 | 1,944 | 1,920 | 1,936 | +31 | +1.6% | 106,300 |
2019/09/18 | 1,949 | 1,953 | 1,893 | 1,905 | -44 | -2.3% | 132,300 |
2019/09/17 | 1,924 | 1,969 | 1,922 | 1,949 | +33 | +1.7% | 164,100 |
2019/09/13 | 1,896 | 1,918 | 1,884 | 1,916 | +24 | +1.3% | 145,300 |
2019/09/12 | 1,896 | 1,906 | 1,880 | 1,892 | -1 | -0.1% | 113,800 |
2019/09/11 | 1,870 | 1,894 | 1,857 | 1,893 | +9 | +0.5% | 120,200 |
2019/09/10 | 1,878 | 1,897 | 1,871 | 1,884 | -1 | -0.1% | 97,300 |
2019/09/09 | 1,850 | 1,885 | 1,845 | 1,885 | +35 | +1.9% | 56,900 |
2019/09/06 | 1,868 | 1,868 | 1,842 | 1,850 | -10 | -0.5% | 49,200 |
2019/09/05 | 1,840 | 1,877 | 1,832 | 1,860 | +25 | +1.4% | 69,800 |
2019/09/04 | 1,832 | 1,842 | 1,825 | 1,835 | -8 | -0.4% | 57,000 |
2019/09/03 | 1,835 | 1,852 | 1,832 | 1,843 | +3 | +0.2% | 35,400 |
2019/09/02 | 1,850 | 1,853 | 1,834 | 1,840 | -24 | -1.3% | 62,500 |
2019/08/30 | 1,848 | 1,869 | 1,840 | 1,864 | +34 | +1.9% | 64,700 |
2019/08/29 | 1,826 | 1,831 | 1,809 | 1,830 | +5 | +0.3% | 57,200 |
2019/08/28 | 1,840 | 1,842 | 1,813 | 1,825 | -23 | -1.2% | 71,400 |
2019/08/27 | 1,859 | 1,867 | 1,842 | 1,848 | +1 | +0.1% | 77,300 |
2019/08/26 | 1,805 | 1,867 | 1,805 | 1,847 | -10 | -0.5% | 107,600 |
2019/08/23 | 1,869 | 1,879 | 1,852 | 1,857 | -7 | -0.4% | 40,000 |
2019/08/22 | 1,857 | 1,869 | 1,846 | 1,864 | +2 | +0.1% | 65,400 |
2019/08/21 | 1,850 | 1,880 | 1,843 | 1,862 | -16 | -0.9% | 90,900 |
2019/08/20 | 1,853 | 1,882 | 1,850 | 1,878 | +22 | +1.2% | 44,100 |
2019/08/19 | 1,850 | 1,860 | 1,842 | 1,856 | +22 | +1.2% | 45,500 |
2019/08/16 | 1,825 | 1,841 | 1,815 | 1,834 | +4 | +0.2% | 39,700 |
2019/08/15 | 1,810 | 1,834 | 1,804 | 1,830 | -24 | -1.3% | 73,400 |
2019/08/14 | 1,862 | 1,870 | 1,833 | 1,854 | +12 | +0.7% | 87,200 |
2019/08/13 | 1,884 | 1,884 | 1,831 | 1,842 | -52 | -2.7% | 103,600 |
2019/08/09 | 1,914 | 1,925 | 1,893 | 1,894 | -7 | -0.4% | 65,200 |
2019/08/08 | 1,895 | 1,902 | 1,870 | 1,901 | ±0 | ±0% | 113,200 |
2019/08/07 | 1,914 | 1,916 | 1,901 | 1,901 | -25 | -1.3% | 66,100 |
2019/08/06 | 1,900 | 1,930 | 1,872 | 1,926 | -15 | -0.8% | 165,400 |
2019/08/05 | 1,988 | 2,035 | 1,917 | 1,941 | -36 | -1.8% | 277,500 |
2019/08/02 | 1,971 | 2,013 | 1,970 | 1,977 | -20 | -1% | 139,000 |
2019/08/01 | 1,984 | 2,002 | 1,962 | 1,997 | +14 | +0.7% | 65,800 |
2019/07/31 | 1,983 | 2,006 | 1,960 | 1,983 | -28 | -1.4% | 459,800 |
1251~
1300
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム